Utility of transbronchial biopsy in the diagnosis of lymphangioleiomyomatosis
Utility of transbronchial biopsy in the diagnosis of lymphangioleiomyomatosis
Riffat Meraj1, Kathryn A. Wikenheiser-Brokamp2, Lisa R. Young3, Sue Byrnes4, Francis X. McCormack1()
1. Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of Cincinnati School of Medicine, Cincinnati, OH 45529, USA; 2. Pathology and Laboratory Medicine, Cincinnati Children’s Hospital Medical Center and University of Cincinnati School of Medicine, Cincinnati, OH 45529, USA; 3. Division of Pediatric Pulmonary Medicine, Department of Pediatrics, Vanderbilt University, Nashville, TN 37232, USA; 4. The LAM Foundation, Executive Drive, Cincinnati, OH 45241, USA
Pulmonary lymphangioleiomyomatosis (LAM) is a rare cystic lung disease that targets women during their reproductive years. A confident diagnosis can often be based on clinical grounds, but diagnostic certainty requires pathological analysis. Although surgical lung biopsy is considered the gold standard for obtaining tissue in patients with diffuse lung disease, it is also associated with higher morbidity and mortality than alternative, less invasive techniques. The objective of our study was to examine the utility of transbronchial biopsy in the diagnosis of LAM. We conducted two online surveys of over 1 000 LAM patients registered with the LAM Foundation who were accessible by email. Transbronchial biopsy specimens were subsequently collected and reviewed by an expert pathologist to validate the diagnosis. We found that transbronchial biopsy has a yield of approximately 60% in patients with LAM. We conclude that transbronchial biopsy may be a safe and effective method for establishing the diagnosis of LAM, obviating the need for surgical lung biopsy in more than half of LAM patients.
Corresponding Author(s):
McCormack Francis X.,Email:frank.mccormack@uc.edu
引用本文:
. Utility of transbronchial biopsy in the diagnosis of lymphangioleiomyomatosis[J]. Frontiers of Medicine, 2012, 6(4): 395-405.
Riffat Meraj, Kathryn A. Wikenheiser-Brokamp, Lisa R. Young, Sue Byrnes, Francis X. McCormack. Utility of transbronchial biopsy in the diagnosis of lymphangioleiomyomatosis. Front Med, 2012, 6(4): 395-405.
8 years of progressive dyspnea, cysts on chest CT, PFTs showing obstruction. Patient is a non-smoker with normal alpha-1 antitrypsin levels; rule out LAM
Travis WD, Colby TV, Corrin B, Shumosato Y, Brambilla E. Histological Typing of Lung and Pleural Tumors. Berlin: Springer. 1999
3
Travis WD, Brambilla E, Muller-Hermlink HK, Harris CC. Pathology and Genetics: Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC. 2004
4
Karbowniczek M, Astrinidis A, Balsara BR, Testa JR, Lium JH, Colby TV, McCormack FX, Henske EP. Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism. Am J Respir Crit Care Med 2003; 167(7): 976–982 doi: 10.1164/rccm.200208-969OC pmid:12411287
5
Bittmann I, Dose TB, Müller C, Dienemann H, Vogelmeier C, Lohrs U. Lymphangioleiomyomatosis: recurrence after single lung transplantations. Hum Pathol 1997; 28(12): 1420–1423 doi: 10.1016/S0046-8177(97)90233-1
6
Taveira-DaSilva AM, Steagall WK, Moss J. Lymphangioleiomyomatosis. Cancer Contr 2006; 13: 276–285
7
Almoosa KF, McCormack FX, Sahn SA. Pleural disease in lymphangioleiomyomatosis. Clin Chest Med 2006; 27(2): 355–368 doi: 10.1016/j.ccm.2006.01.005 pmid:16716823
8
Johnson SR, Tattersfield AE. Clinical experience of lymphangioleiomyomatosis in the UK. Thorax 2000; 55(12): 1052–1057 doi: 10.1136/thorax.55.12.1052 pmid:11083892
9
Johnson SR, Cordier JF, Lazor R, Cottin V, Costabel U, Harari S, Reynaud-Gaubert M, Boehler A, Brauner M, Popper H, Bonetti F, Kingswood C, Review Panel of the ERS LAM Task Force. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J 2010; 35(1): 14–26 doi: 10.1183/09031936.00076209 pmid:20044458
10
Young LR, Vandyke R, Gulleman PM, Inoue Y, Brown KK, Schmidt LS, Linehan WM, Hajjar F, Kinder BW, Trapnell BC, Bissler JJ, Franz DN, McCormack FX. Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases. Chest 2010; 138(3): 674–681 doi: 10.1378/chest.10-0573 pmid:20382711
11
Hirama M, Atsuta R, Mitani K, Kumasaka T, Gunji Y, Sasaki S, Iwase A, Takahashi K, Seyama K. Lymphangioleiomyomatosis diagnosed by immunocytochemical and genetic analysis of lymphangioleiomyomatosis cell clusters found in chylous pleural effusion. Intern Med 2007; 46(18): 1593–1596 doi: 10.2169/internalmedicine.46.0225 pmid:17878649
12
Andersen HA, Miller WE, Bernatz PE. Lung biopsy: transbronchoscopic, percutaneous, open. Surg Clin North Am 1973; 53(4): 785–793 pmid:4352129
13
Levin DC, Wicks AB, Ellis JH Jr. Transbronchial lung biopsy via the fiberoptic bronchoscope. Am Rev Respir Dis 1974; 110(1): 4–12 pmid:4545899
14
Mack MJ, Aronoff RJ, Acuff TE, Douthit MB, Bowman RT, Ryan WH. Present role of thoracoscopy in the diagnosis and treatment of diseases of the chest. Ann Thorac Surg 1992; 54(3): 403–408 , discussion 407–409 doi: 10.1016/0003-4975(92)90428-7 pmid:1510505
15
Kreider ME, Hansen-Flaschen J, Ahmad NN, Rossman MD, Kaiser LR, Kucharczuk JC, Shrager JB. Complications of video-assisted thoracoscopic lung biopsy in patients with interstitial lung disease. Ann Thorac Surg 2007; 83(3): 1140–1144 doi: 10.1016/j.athoracsur.2006.10.002 pmid:17307476
16
Messika J, Parquin F, Puyo P, Sage E, Bonnette P, Rivaud E, Catherinot E, Couderc LJ, Chapelier A. Lung surgery in haematological patients: useful? hazardous?Rev Pneumol Clin 2011; 67(4): 220–225 (in French) doi: 10.1016/j.pneumo.2011.06.002 pmid:21920281
17
Quadrelli S, Lyons G, Ciallella L, Iotti A, Chertcoff J. Lung biopsy for the diagnosis of interstitial lung disease. Medicina (B Aires) 2007; 67(6 Pt 2): 691–697 (in Spanish) pmid:18422059
18
Hanson RR, Zavala DC, Rhodes ML, Keim LW, Smith JD. Transbronchial biopsy via flexible fiberoptic bronchoscope; results in 164 patients. Am Rev Respir Dis 1976; 114(1): 67–72 pmid:937843
19
Prakash UBS. Bronchoscopy. New York: Raven Press. 1994
20
Herf SM, Suratt PM, Arora NS. Deaths and complications associated with transbronchial lung biopsy. Am Rev Respir Dis 1977; 115(4): 708–711 pmid:848796
21
Simpson FG, Arnold AG, Purvis A, Belfield PW, Muers MF, Cooke NJ. Postal survey of bronchoscopic practice by physicians in the United Kingdom. Thorax 1986; 41(4): 311–317 doi: 10.1136/thx.41.4.311 pmid:3738850
22
Frazier WD, Pope TL Jr, Findley LJ. Pneumothorax following transbronchial biopsy. Low diagnostic yield with routine chest roentgenograms. Chest 1990; 97(3): 539–540 doi: 10.1378/chest.97.3.539 pmid:2306956
23
de Fenoyl O, Capron F, Lebeau B, Rochemaure J. Transbronchial biopsy without fluoroscopy: a five year experience in outpatients. Thorax 1989; 44(11): 956–959 doi: 10.1136/thx.44.11.956 pmid:2595639
24
Anders GT, Johnson JE, Bush BA, Matthews JI. Transbronchial biopsy without fluoroscopy. A seven-year perspective. Chest 1988; 94(3): 557–560 doi: 10.1378/chest.94.3.557 pmid:3409736
25
Hernández Blasco L, Sánchez Hernández IM, Villena Garrido V, de Miguel Poch E, Nu?ez Delgado M, Alfaro Abreu J. Safety of the transbronchial biopsy in outpatients. Chest 1991; 99(3): 562–565 doi: 10.1378/chest.99.3.562 pmid:1995209
Bonetti F, Chiodera PL, Pea M, Martignoni G, Bosi F, Zamboni G, Mariuzzi GM. Transbronchial biopsy in lymphangiomyomatosis of the lung. HMB45 for diagnosis. Am J Surg Pathol 1993; 17(11): 1092–1102 doi: 10.1097/00000478-199311000-00002 pmid:8214254
28
Hayashida M, Seyama K, Inoue Y, Fujimoto K, Kubo K; Respiratory Failure Research Group of the Japanese Ministry of Health, Labor, and Welfare. The epidemiology of lymphangioleiomyomatosis in Japan: a nationwide cross-sectional study of presenting features and prognostic factors. Respirology 2007; 12(4): 523–530 doi: 10.1111/j.1440-1843.2007.01101.x pmid:17587419
29
Chu SC, Horiba K, Usuki J, Avila NA, Chen CC, Travis WD, Ferrans VJ, Moss J. Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis. Chest 1999; 115(4): 1041–1052 doi: 10.1378/chest.115.4.1041 pmid:10208206
30
Kitaichi M, Nishimura K, Itoh H, Izumi T. Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors. Am J Respir Crit Care Med 1995; 151(2 Pt 1): 527–533 pmid:7842216
31
H?ie J, J?rstad SO, Odegaard A. Pulmonary lymphangioleiomyomatosis. Tidsskr Nor Laegeforen 1995; 115(10): 1230–1232 pmid:7754491
32
Benden C, Rea F, Behr J, Corris PA, Reynaud-Gaubert M, Stern M, Speich R, Boehler A. Lung transplantation for lymphangioleiomyomatosis: the European experience. J Heart Lung Transplant 2009; 28(1): 1–7 pmid:19134523
33
Seyama K, Kira S, Takahashi H, Ohnishi M, Kodama Y, Dambara T, Kobayashi J, Kitamura S, Fukuchi Y. Longitudinal follow-up study of 11 patients with pulmonary lymphangioleiomyomatosis: diverse clinical courses of LAM allow some patients to be treated without anti-hormone therapy. Respirology 2001; 6(4): 331–340 doi: 10.1046/j.1440-1843.2001.00343.x pmid:11844125
34
Lim KE, Tsai YH, Hsu Yl Y, Hsu Wc W. Pulmonary lymphangioleiomyomatosis. High-resolution CT findings in 11 patients and compared with the literature. Clin Imaging 2004; 28(1): 1–5 doi: 10.1016/S0899-7071(03)00030-5 pmid:14996439
35
Taylor JR, Ryu J, Colby TV, Raffin TA. Lymphangioleiomyomatosis. Clinical course in 32 patients. N Engl J Med 1990; 323(18): 1254–1260 doi: 10.1056/NEJM199011013231807 pmid:2215609
36
Naalsund A, Johansen B, Foerster A, Kolbenstvedt A. When to suspect and how to diagnose pulmonary lymphangioleiomyomatosis. Respirology 1996; 1(3): 207–212 doi: 10.1111/j.1440-1843.1996.tb00034.x pmid:9424398
37
Torre O, Harari S. The diagnosis of cystic lung diseases: a role for bronchoalveolar lavage and transbronchial biopsy? Respir Med 2010; 104(Suppl 1): S81–S85 doi: 10.1016/j.rmed.2010.03.021 pmid:20430602
38
Ye L, Jin M, Bai C. Clinical analysis of patients with pulmonary lymphangioleiomyomatosis (PLAM) in mainland China. Respir Med 2010; 104(10): 1521–1526 doi: 10.1016/j.rmed.2010.05.003 pmid:20627505
39
Chen F, Bando T, Fukuse T, Omasa M, Aoyama A, Hamakawa H, Fujinaga T, Shoji T, Sakai H, Hanaoka N, Wada H. Recurrent lymphangioleiomyomatosis after living-donor lobar lung transplantation. Transplant Proc 2006; 38(9): 3151–3153 doi: 10.1016/j.transproceed.2006.08.145 pmid:17112924
40
Unger PD, Hoffman K, Thung SN, Pertsemlides D, Wolfe D, Kaneko M. HMB-45 reactivity in adrenal pheochromocytomas. Arch Pathol Lab Med 1992; 116(2): 151–153 pmid:1733408
Curley FJ, Johal JS, Burke ME, Fraire AE. Transbronchial lung biopsy: can specimen quality be predicted at the time of biopsy? Chest 1998; 113(4): 1037–1041 doi: 10.1378/chest.113.4.1037 pmid:9554644
43
Chilosi M, Pea M, Martignoni G, Brunelli M, Gobbo S, Poletti V, Bonetti F. Cathepsin-k expression in pulmonary lymphangioleiomyomatosis. Mod Pathol 2009; 22(2): 161–166
Ferrans VJ, Yu ZX, Nelson WK, Valencia JC, Tatsuguchi A, Avila NA, Riemenschn W, Matsui K, Travis WD, Moss J. Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features. J Nippon Med Sch 2000; 67(5): 311–329 doi: 10.1272/jnms.67.311 pmid:11031360
46
McCormack FX, Inoue Y, Moss J, Singer LG, Strange C, Nakata K, Barker AF, Chapman JT, Brantly ML, Stocks JM, Brown KK, Lynch JP 3rd, Goldberg HJ, Young LR, Kinder BW, Downey GP, Sullivan EJ, Colby TV, McKay RT, Cohen MM, Korbee L, Taveira-DaSilva AM, Lee HS, Krischer JP, Trapnell BC; National Institutes of Health Rare Lung Diseases Consortium; MILES Trial Group. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med 2011; 364(17): 1595–606 doi: 10.1056/NEJMoa1100391 pmid:11031360
